Crossref
75373 Characterizing Polypharmacy in Eczema: Patterns, Profiles, and Clinical Implications
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB99
DOI: 10.1016/j.jaad.2026.04.404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Bryan Mantell und 2 weiteren Autor:innen.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mantell, B., Thibau, I., & Begolka, W. S. (2026). 75373 Characterizing Polypharmacy in Eczema: Patterns, Profiles, and Clinical Implications. Journal of the American Academy of Dermatology, 95(1), AB99. https://doi.org/10.1016/j.jaad.2026.04.404
Vancouver
Mantell B, Thibau I, Begolka WS. 75373 Characterizing Polypharmacy in Eczema: Patterns, Profiles, and Clinical Implications. Journal of the American Academy of Dermatology. 2026;95(1):AB99. doi:10.1016/j.jaad.2026.04.404
BibTeX
@article{Mantell2026,
author = {Mantell, Bryan and Thibau, Isabelle and Begolka, Wendy Smith},
title = {75373 Characterizing Polypharmacy in Eczema: Patterns, Profiles, and Clinical Implications},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB99},
doi = {10.1016/j.jaad.2026.04.404}
}
EUVIMED